Wright RO et al., 1999-11: Clinical review of methaemoglobinemia that describes methylene blue as the treatment and sets out the enzyme deficiencies, including G6PD deficiency, that complicate its use.
Treatment with methylene blue can be complicated by the presence of underlying enzyme deficiencies, including glucose-6-phosphate dehydrogenase deficiency.
n/a (abstract)
Wright RO et al., 1999-11: Clinical review of methaemoglobinemia that describes methylene blue as the treatment and sets out the enzyme deficiencies, including G6PD deficiency, that complicate its use. Narrative review, no N. PMID 10533013; DOI 10.1016/S0196-0644(99)70167-8. The review states that methylene blue acts as an electron acceptor for NADPH-dependent methaemoglobin reductase, the pathway in which G6PD supplies NADPH. Funding/conflicts not returned in the PubMed record. Study type: review.
